metastatic renal cell carcinoma: lenvatinib phase ii data
Published 8 years ago • 215 plays • Length 4:28Download video MP4
Download video MP3
Similar videos
-
1:32
phase 2 trial of lenvatinib and everolimus in metastatic renal cell carcinoma
-
8:43
optimizing the upfront treatment of metastatic renal cell carcinoma
-
1:19
phase 2 trial of lenvatinib and everolimus for metastatic renal cell carcinoma
-
6:43
metastatic renal cell carcinoma: emerging data, future directions
-
4:27
lenvatinib in renal cell carcinoma
-
6:23
second-line treatment of metastatic renal cell carcinoma
-
7:34
frontline sunitinib compared to everolimus in metastatic renal cell carcinoma
-
3:36
first-line treatment of poor-risk metastatic renal cell carcinoma
-
4:38
determining progression in metastatic renal cell carcinoma
-
5:19
lenvatinib and cabozantinib in renal cell carcinoma
-
12:49
the tivo-3 study of tivozanib in metastatic renal cell carcinoma
-
1:22
discussing the phase ii study of lenvatinib/pembrolizumab in metastatic ccrcc
-
7:37
lenvatinib as up-front therapy for unresectable hcc
-
6:53
treatment of metastatic non-clear cell renal cell carcinoma
-
5:31
newly diagnosed metastatic renal cell carcinoma
-
12:07
evidence in first-line metastatic renal cell carcinoma
-
2:25
dr. tykodi on the keynote-427 trial with pembrolizumab in rcc
-
6:42
the role of lenvatinib in advanced rcc
-
1:32
three-arm trial of lenvatinib and everolimus for metastatic renal cell carcinoma